Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05121337 · ClinicalTrials.gov registry record · NA

Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension

A NA study of Hypertension and Elevated Blood Pressure, sponsored by Beth Israel Deaconess Medical Center.

Active
Registry status
NA
Development phase
150
Enrollment target
1
Study location

NCT05121337 is a NA study of Hypertension and Elevated Blood Pressure that is active but no longer recruiting, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 150 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05121337, a NA study of Hypertension and Elevated Blood Pressure, is active but no longer recruiting, sponsored by Beth Israel Deaconess Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

GoFresh is a randomized trial, testing the effects of a home-delivered DASH-patterned grocery intervention on blood pressure in Black adults, residing in Boston area urban food deserts.

Interventions

  • BEHAVIORAL Dietitian-Assisted DASH groceries
  • BEHAVIORAL Self-directed shopping

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Clinical Research Center - Boston

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2022-09-30
Est. Completion 2026-02
Phase NA

What the Registry Record Tells You About NCT05121337

The ClinicalTrials.gov registry entry for NCT05121337 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Dietitian-Assisted DASH groceries is the first listed.

NCT05121337 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05121337 about?

NCT05121337 is a clinical study titled "Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension". GoFresh is a randomized trial, testing the effects of a home-delivered DASH-patterned grocery intervention on blood pressure in Black adults, residing in Boston area urban food deserts.

What is the current status of trial NCT05121337?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2022-09-30. Estimated completion is 2026-02.

What conditions does trial NCT05121337 study?

This clinical trial studies the following conditions: Hypertension, Elevated Blood Pressure.

What interventions are being tested in trial NCT05121337?

The interventions under investigation include: Dietitian-Assisted DASH groceries (BEHAVIORAL), Self-directed shopping (BEHAVIORAL).

Who is sponsoring clinical trial NCT05121337?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05121337 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.